Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Operating Margin (2016 - 2025)

Historic Operating Margin for Ekso Bionics Holdings (EKSO) over the last 13 years, with Q3 2025 value amounting to 33.17%.

  • Ekso Bionics Holdings' Operating Margin rose 307500.0% to 33.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 74.9%, marking a year-over-year decrease of 88500.0%. This contributed to the annual value of 58.35% for FY2024, which is 243200.0% up from last year.
  • Ekso Bionics Holdings' Operating Margin amounted to 33.17% in Q3 2025, which was up 307500.0% from 193.24% recorded in Q2 2025.
  • Ekso Bionics Holdings' 5-year Operating Margin high stood at 33.17% for Q3 2025, and its period low was 193.24% during Q2 2025.
  • For the 5-year period, Ekso Bionics Holdings' Operating Margin averaged around 101.02%, with its median value being 97.0% (2022).
  • In the last 5 years, Ekso Bionics Holdings' Operating Margin soared by 1613400bps in 2021 and then crashed by -1460700bps in 2025.
  • Quarter analysis of 5 years shows Ekso Bionics Holdings' Operating Margin stood at 111.68% in 2021, then decreased by -12bps to 124.92% in 2022, then surged by 43bps to 71.16% in 2023, then soared by 38bps to 43.81% in 2024, then increased by 24bps to 33.17% in 2025.
  • Its Operating Margin was 33.17% in Q3 2025, compared to 193.24% in Q2 2025 and 101.93% in Q1 2025.